TACHOSIL
Biological
BAXTER HEALTHCARE
Total Payments
$43,006
Transactions
823
Doctors
668
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $544.21 | 27 | 27 |
| 2022 | $9,189 | 167 | 156 |
| 2021 | $3,659 | 124 | 101 |
| 2020 | $3,054 | 78 | 67 |
| 2019 | $3,040 | 91 | 79 |
| 2018 | $19,722 | 245 | 211 |
| 2017 | $3,797 | 91 | 84 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $32,141 | 818 | 74.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,380 | 1 | 17.2% |
| Education | $1,500 | 1 | 3.5% |
| Travel and Lodging | $1,409 | 2 | 3.3% |
| Unspecified | $576.00 | 1 | 1.3% |
Payments by Type
General
$42,430
822 transactions
Research
$576.00
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A RANDOMIZED, OPEN LABEL, PARALLEL-GROUP, MULTI-CENTER TRIAL TO COMPARE EFFICACY AND SAFETY OF TACHOSIL? VERSUS SURGICEL? ORIGINAL FOR THE SECONDARY HEMOSTATIC TREATMENT OF NEEDLE HOLE BLEEDING IN VASCULAR SURGERY | Takeda Pharmaceuticals U.S.A., Inc. | $576.00 | 0 |
Top Doctors Receiving Payments for TACHOSIL — Page 27
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Surgery | Fountain Hill, PA | $10.71 | 1 |
| , M.D | Surgical Critical Care | Bethlehem, PA | $10.71 | 1 |
| , M.D | Surgery | Cleveland, OH | $10.71 | 1 |
| , M.D | Surgery | Dearborn, MI | $10.59 | 1 |
| , M.D | Anesthesiology | Los Angeles, CA | $10.47 | 1 |
| , M.D | Obstetrics & Gynecology | West Hollywood, CA | $10.47 | 1 |
| , M.D | Anesthesiology | Loma Linda, CA | $10.47 | 1 |
| , PA-C | Physician Assistant | New Haven, CT | $9.33 | 1 |
| Kerry Colatruglio | Physician Assistant | Cleveland, OH | $9.33 | 1 |
| , MD | Surgery | Stanford, CA | $8.79 | 1 |
| , MD | Surgery | Columbia, MO | $8.79 | 1 |
| , PA | Surgical | Baton Rouge, LA | $7.17 | 1 |
| , MD | Surgery | Tampa, FL | $7.09 | 1 |
| Kevin Knapp | Surgical | Greenville, SC | $6.97 | 2 |
| , MPAS PA-C | Physician Assistant | Colleyville, TX | $6.29 | 1 |
| , M.D | Surgery | Fort Worth, TX | $6.29 | 1 |
| Michelle Uzor | Gynecology | Atlanta, GA | $4.85 | 1 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | San Diego, CA | $4.31 | 1 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Binghamton, NY | $3.98 | 1 |
Ad
Manufacturing Companies
- BAXTER HEALTHCARE $25,730
- Baxter Healthcare $16,700
- Takeda Pharmaceuticals U.S.A., Inc. $576.00
Product Information
- Type Biological
- Total Payments $43,006
- Total Doctors 668
- Transactions 823
About TACHOSIL
TACHOSIL is a biological associated with $43,006 in payments to 668 healthcare providers, recorded across 823 transactions in the CMS Open Payments database. The primary manufacturer is BAXTER HEALTHCARE.
Payment data is available from 2017 to 2023. In 2023, $544.21 was paid across 27 transactions to 27 doctors.
The most common payment nature for TACHOSIL is "Food and Beverage" ($32,141, 74.7% of total).
TACHOSIL is associated with 1 research study, including "A RANDOMIZED, OPEN LABEL, PARALLEL-GROUP, MULTI-CENTER TRIAL TO COMPARE EFFICACY AND SAFETY OF TACHOSIL? VERSUS SURGICEL? ORIGINAL FOR THE SECONDARY HEMOSTATIC TREATMENT OF NEEDLE HOLE BLEEDING IN VASCULAR SURGERY" ($576.00).